Skip to content

Clinical trials

Phase 1/2 Brain Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 1/2 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20142
20161
20172
20203
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
AstraZeneca1
BBB-Therapeutics B.V.1
BeiGene USA, Inc.1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Institut de Recherches Internationales Servier1
Stemline Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms14
Breast Neoplasms4
Central Nervous System Neoplasms4
Glioblastoma4
Glioma4
Neoplasms3
Neoplasms by Site3
Neuroblastoma3
Brain Diseases2
Central Nervous System Diseases2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.